SCM
JNJ icon

Sandler Capital Management’s Johnson & Johnson JNJ Stock Holding History

Sandler Capital Management’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-148,700
Closed -$13.9M – 163
2015
Q3 		$13.9M Buy
+148,700
New +$14.4M 1.61% 13

Other funds holding JNJ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.88B AUM 29.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Sandler Capital Management's JNJ Position: Q4 2024 in Review

Sandler Capital Management sold out of Johnson & Johnson (JNJ) in Q4 2024, closing a stake of 25,892 shares — an estimated $4.2M sold.

Sandler Capital Management first reported a position in JNJ in Q2 2016 and held it in 6 quarters. The position peaked at $6.55M in Q2 2016. 4,105 funds tracked by Wall St. Rank hold JNJ as of Q4 2024.

  • Sandler Capital Management reported no remaining Johnson & Johnson position as of Q4 2024 after selling out during the quarter.
  • Sandler Capital Management sold 25,892 Johnson & Johnson shares in Q4 2024, an estimated $4.2M.
  • Sandler Capital Management first reported a position in Johnson & Johnson in Q2 2016 and held it in 6 quarters.
  • Sandler Capital Management's Johnson & Johnson position peaked at $6.55M in Q2 2016.
  • 4,105 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2024.

Based on Sandler Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.